Articles for category: Micro Cap Stocks

January 4, 2024

Ron Finklestien

Investors Cheer Positive Results in Atai Life Sciences MDMA Study Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment

Biopharma firm Atai Life Sciences ATAI has announced the positive outcomes of a Phase 1 clinical study on MDMA R-enantiomer, EMP-01, developed for the potential treatment of PTSD. Assessing EMP-01’s safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD,) the study enrolled 32 healthy participants. They were divided into four cohorts that received one dose of 75mg, 125mg, 175mg, or 225mg of EMP-01 or placebo in a 6+2 design. Atai  reported that: The compound was well-tolerated, and treatment-related adverse events were all expected, none severe and generally dose-dependent. Non-clinically significant increases in blood pressure and heart rate were observed, yet changes showed limited dose dependency.

January 4, 2024

Ron Finklestien

The Soaring and Plummeting of Sellas Life Sciences Stocks

January 4, 2024 12:56 PM | 1 min read Sellas Life Sciences stocks have plummeted by 35.7% on Thursday. The company’s announcement of a $9 million public offering has led to the decline. Sellas Life Sciences Group Inc SLS shares are trading lower by 35.7% to $0.58 Thursday afternoon. The stock is trading lower after the company announced pricing of a $9 million public offering. Untangling the Web The issuance of 12 million shares of common stock alongside accompanying warrants aims to raise $9 million before expenses. Priced at $0.75 per share and warrant, these securities will grant the option

January 4, 2024

Ron Finklestien

Bitcoin Miner Hive Digital’s Stock Surge Bitcoin Miner Hive Digital’s Stock Surge

The Rise of HIVE Digital Technologies Ltd HIVE Digital Technologies Ltd HIVE shares are trading higher. The company on Thursday provided an operations update for December. Deciphering the Surge What Happened: Hive Digital said it produced 282.8 Bitcoin in December as it maintained an average hashrate of 3.95 EH/s during the month. The company produced an average of 9.1 bitcoin per day, representing approximately 1% of the global network. As of the end of December, Hive had 4.08 EH/s of mining capacity. Operations Update Hive noted that its New Brunswick facility is currently operating at 1.8 EH/s while undergoing final

January 4, 2024

Ron Finklestien

Jeffs’ Brands Stock Surges After Major Deals Jeffs’ Brands Stock Surges After Major Deals

Jeffs’ Brands, Ltd. JFBR shares are moving higher Thursday. The stock appears to be moving on continued upward momentum after gaining 25% on Wednesday. What’s Happening with Jeffs’ Brands? Jeffs’ Brands recently signed a letter of intent with Sky Growth Partners Ltd. to invest in and develop defense solutions against drone-based visual systems, as well as wireless charging technology systems for the remote charging of drones, in mid-December. The company also announced an exclusive distribution agreement with Bolly Jon Ltd., a biotech-beauty hair care product brand, to distribute the line of hair products through Amazon Marketplace in December. Jeffs’ Brands’

January 4, 2024

Ron Finklestien

Novo Nordisk Collaborates for Cardiometabolic Diseases Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases

Introduction Novo Nordisk A/S (NVO), Omega Therapeutics Inc (OMGA), and Cellarity Inc have joined forces in groundbreaking research collaborations. These partnerships have the potential to revolutionize treatments for cardiometabolic diseases, offering hope in the realm of obesity management and chronic liver diseases such as MASH. Omega Therapeutics Collaboration Omega will use its proprietary platform technology to develop an epigenomic controller aimed at enhancing metabolic activity. This novel approach holds promise for potential breakthroughs in the treatment of obesity. Cellarity Collaboration The collaboration with Cellarity focuses on delving into the biological drivers of MASH. Leveraging Cellarity’s platform, the goal is to

January 4, 2024

Ron Finklestien

Carrefour Ceases Selling PepsiCo Products in France: Inflation Takes Its Toll Carrefour Ceases Selling PepsiCo Products in France: Inflation Takes Its Toll

In a bold move, French retail powerhouse Carrefour SACRRFY has reportedly decided to discontinue selling products from PepsiCo IncPEP, including popular items like Pepsi, Lay’s crisps, and 7up, citing unwarranted price hikes. Starting Thursday, Carrefour stores across France will prominently display notices informing consumers of the termination of PepsiCo products due to their “unacceptable price increases,” as reported by Reuters. This move comes in the wake of PepsiCo’s announcement in October about planned incremental price increases due to sustained demand. The brewing conflict reflects a wider trend where retailers in various countries, such as Germany and Belgium, have halted orders

January 4, 2024

Ron Finklestien

Beamr Partners With Nvidia to Revolutionize Video Optimization Powered By Nvidia, Beamr Aims To Disrupt The Video World

Video is ubiquitous in today’s digital landscape. From streaming services like Netflix and Amazon Prime to social media platforms and personal messaging apps, it consumes a staggering 80% of global online traffic. This escalating demand for digital space is driving the AI and machine learning sectors, as well as the need for efficient video processing in various industries. In this vast video-scape, cost and complexity are formidable hurdles. The likes of Google and Meta have the resources to navigate these challenges, but many businesses grapple with the expense and technical demands of video processing. Enter Beamr BMR. With its patented

January 4, 2024

Ron Finklestien

Warning Signs in the Energy Sector: A Deep Dive into Two Stocks Warning Signs in the Energy Sector: A Deep Dive into Two Stocks

As of Jan. 4, 2024, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The Relative Strength Index (RSI), a momentum indicator, is comparing a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here’s the

January 3, 2024

Ron Finklestien

What’s Happening with Trinity Place Holdings Stock? What’s Happening with Trinity Place Holdings Stock?

Trinity Place Holdings Inc. TPHS shares are significantly surging on Wednesday after the company reported that its mortgage lender has extended the mortgage loan forbearance period to Jan. 31. The Extension Details: In an 8k filed on Tuesday, Trinity Place Holdings announced that its mortgage lender, Macquarie PF Inc., has agreed to extend the mortgage loan forbearance period to Jan. 31. Compliance Concerns: Trinity Place Holdings received notice from the NYSE American on Nov. 29, informing the company that it is not in compliance with the NYSE American continued listing standards. This non-compliance is due to the reported stockholders’ deficit

January 3, 2024

Ron Finklestien

ABVC BioPharma Inc Stock Surge The Rise of ABVC BioPharma: A Plant-Based Medication Success Story

ABVC BioPharma Inc ABVC and its subsidiary BioLite Inc received an aggregate of 46 million shares from AiBtl BioPharma Inc as its first milestone payment under a global licensing agreement.  The agreement between the company and AiBtl placed a value of $460 ($10 per share) on such payment.  The company entered into a definitive global licensing agreement with AiBtl in November 2023, for its CNS drugs with the indications of MDD (Major Depressive Disorder) and ADHD (Attention Deficit Hyperactivity Disorder).  According to the terms of the agreement, AiBtl delivered 46M shares to ABVC BioPharma as the first milestone payment.  The company expects AiBtl to achieve further